Dechra Pharmaceuticals PLC

Dechra Pharmaceuticals PLC

Annual Report and Accounts for the year ended 30 June 2012

The Business and its Markets

Dechra operates under four segments:

  • Product Development;
  • European Pharmaceuticals which comprises Dechra Veterinary Products Europe (including Eurovet) ("DVP EU") and Dechra Manufacturing;
  • US Pharmaceuticals comprising Dechra Veterinary Products US ("DVP US"); and
  • Services comprising National Veterinary Services ("NVS") and our Laboratories, Dechra Laboratory Services ("DLS") and Dechra Specialist Laboratories ("DSL").

The Group employs 1,237 people, operates out of 14 countries and exports products globally to over 40 countries.


We use cookies and track users anonymously, check this box and save to disable. We are inferring consent by continuing.